Us Stem Cell Inc. (USRM)

Overview

U.S. Stem Cell, Inc. is a pioneering biotechnology company based in Sunrise, Florida, focusing on the discovery, development, and commercialization of autologous cellular therapies. These therapies are aimed at treating a variety of conditions, including chronic and acute heart damage, vascular diseases, and autoimmune disorders. Initially founded in 1999 under the name Bioheart, Inc., the company underwent a rebranding to U.S. Stem Cell, Inc. in October 2015. Their work encompasses a range of leading-edge product candidates and services designed to leverage the healing potential of stem cells derived from the patient’s own body.

Products and Services

• MyoCell

  MyoCell is a clinical-stage therapy designed to improve cardiac function in patients suffering from chronic heart failure. This innovative approach involves populating scar tissue within the heart with autologous muscle cells—cells harvested from the patient's body. The primary goal is to enhance cardiac performance and patient quality of life through regenerative medicine.

• AdipoCell

  A patient-derived cell therapy aimed at treating acute myocardial infarction, chronic heart ischemia, and lower limb ischemia. AdipoCell represents a frontier in utilizing patient's own cells to address severe cardiovascular diseases, offering new hope for recovery and rehabilitation.

• MyoCell SDF-1

  This pipeline product extends the MyoCell technology by specifically aiming to improve cardiac function in patients with chronic heart failure. It involves an autologous muscle-derived cellular therapy, which shows promise in further enhancing the therapeutic outcomes for heart failure patients.

• MyoCath

  MyoCath is a specially designed catheter with a deflecting tip needle intended for the therapeutic injection of cells into cardiac tissue. This device is pivotal in the treatment of chronic heart ischemia and congestive heart failure, facilitating the direct delivery of cell therapies to the areas of the heart most in need.

• Regenerative Medicine/Cell Therapy Training and Services

  U.S. Stem Cell, Inc. not only develops therapies but also provides comprehensive training for physicians and healthcare professionals in the field of regenerative medicine and cell therapy. Additionally, the company offers services in cell collection and storage, alongside cell collection and treatment kits for both human and veterinary applications. A dedicated clinic is operated by the company to administer cellular treatments for a broad spectrum of diseases, including neurological, autoimmune, orthopedic, and degenerative conditions, making U.S. Stem Cell, Inc. a full-service provider in the regenerative medicine space.